Anavex Life Sciences Corp (AVXL)

[nidan7500]

Thanks RedShoulder

By Massachusetts General Hospital on Oct 15, 2021

“Our results suggest that the sigma-1 receptor might be a viable therapeutic target for reducing Abeta production, specifically in axons,”

https://scitechdaily.com/alzheimers-mystery-solved-how-amyloid-beta-forms-in-brain-nerve-cells/amp/

Thanks Red shoulder. We keep score, not only of nominally positive/MOA supportive research comments, but we keep an eye open for contradictions.

IMO, at some point, well funded and precision research also continuously presents an opportunity to show/rattle any potential AVXL skeletons that might be found. AVXL MOA is out there for the scientific world to review and to use for target practice. BTW-Many, multiple such papers did in past point out the scientific flaws in the Amyloid Thesis (for example) and rightfully so.

So, everyone keep watch on the horizon for any signs of weakness or technical flaws in AVXL MOA thesis. Any such science contradictions must be analyzed and responded to. (belt and suspenders)